Related references
Note: Only part of the references are listed.PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer
Taisuke Yagi et al.
ANNALS OF SURGERY (2019)
Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair
Xue-Cen Wang et al.
CLINICAL CANCER RESEARCH (2019)
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer
Trine Vilsboll Larsen et al.
CANCER COMMUNICATIONS (2019)
Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell
Qiang-hua Zhou et al.
CELL DEATH & DISEASE (2018)
The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
Sarah Rosanne Ottenhof et al.
FRONTIERS IN IMMUNOLOGY (2018)
Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma
Qiang-Hua Zhou et al.
CANCER MANAGEMENT AND RESEARCH (2018)
A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer
Zai-Shang Li et al.
CANCER COMMUNICATIONS (2018)
Cellular metabolism of tumor-associated macrophages - functional impact and consequences
Katrin Rabold et al.
FEBS LETTERS (2017)
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
Chun-mei Kuang et al.
CELL DEATH & DISEASE (2017)
Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma
Chuangzhong Deng et al.
ONCOIMMUNOLOGY (2017)
Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study
Li-Yang Hu et al.
CHINESE JOURNAL OF CANCER (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival
Lijie Zhai et al.
CLINICAL CANCER RESEARCH (2017)
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Yuan Gao et al.
CHINESE JOURNAL OF CANCER (2017)
First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2017)
The loss-of-function mutations and down-regulated expression of ASB3 gene promote the growth and metastasis of colorectal cancer cells
Wu-Ying Du et al.
CHINESE JOURNAL OF CANCER (2017)
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches
A. M. Udager et al.
ANNALS OF ONCOLOGY (2016)
Pathophysiological Basis of Human Papillomavirus in Penile Cancer: Key to Prevention and Delivery of More Effective Therapies
Philippe E. Spiess et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis
Jieping Chen et al.
ONCOTARGET (2016)
A Phase I study of indoximod in patients with advanced malignancies
Hatem H. Soliman et al.
ONCOTARGET (2016)
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy
Aitziber Buque et al.
ONCOIMMUNOLOGY (2016)
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma
Ayako Masaki et al.
CLINICAL CANCER RESEARCH (2015)
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
Lijie Zhai et al.
CLINICAL CANCER RESEARCH (2015)
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Nicolas A. Giraldo et al.
CLINICAL CANCER RESEARCH (2015)
EAU Guidelines on Penile Cancer: 2014 Update
Oliver W. Hakenberg et al.
EUROPEAN UROLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan
Nicolas van Baren et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival
Debbie M. Ferns et al.
ONCOIMMUNOLOGY (2015)
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
Roberto Bellucci et al.
ONCOIMMUNOLOGY (2015)
Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
Sonia Moretti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Gene Expression-Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin Lymphoma
David W. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
Li-xia Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Overexpression of Asparagine Synthetase and Matrix Metalloproteinase 19 Confers Cisplatin Sensitivity in Nasopharyngeal Carcinoma Cells
Ran-Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinoma
Ran-yi Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Courtney Smith et al.
CANCER DISCOVERY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Sergio A. Quezada et al.
IMMUNOLOGICAL REVIEWS (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma
R-Y Liu et al.
ONCOGENE (2011)
Minicircle-oriP-IFNγ: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma
Yufang Zuo et al.
PLOS ONE (2011)
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Joshua D. Mezrich et al.
JOURNAL OF IMMUNOLOGY (2010)
Clinical Use of Interferon-gamma
Catriona H. T. Miller et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
Dendritic cells modified with 6Ckine/IFNγ fusion gene induce specific cytotoxic T lymphocytes in vitro
Gang Xue et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Adenovirus-mediated delivery of human IFNγ gene inhibits prostate cancer growth
Peng Zhao et al.
LIFE SCIENCES (2007)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
The roles of IFNγ in protection against tumor development and cancer immunoediting
H Ikeda et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Share Paper
